MarketCapTrends
TMO

Thermo Fisher Scientific Inc.

NYSE · Healthcare

Thermo Fisher Scientific Inc. annual/quarterly operating income history and growth rate from 2007 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.

  • Thermo Fisher Scientific Inc. operating income for the quarter ending March 28, 2026 was 1.9 B, a 8.57% increase year-over-year.
  • Thermo Fisher Scientific Inc. operating income for the twelve months ending March 28, 2026 was 7.4 B, a 2.35% increase year-over-year.
  • Thermo Fisher Scientific Inc. annual operating income for 2025 was 7.7 B, a 5.57% increase from 2024.
  • Thermo Fisher Scientific Inc. annual operating income for 2024 was 7.3 B, a 6.97% increase from 2023.
  • Thermo Fisher Scientific Inc. annual operating income for 2023 was 6.9 B, a 18.28% decrease from 2022.
  • Thermo Fisher Scientific Inc. annual operating income for 2022 was 8.4 B.
Operating Income
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %